Tag : MedicinalGenomics

CCT Impact

Rose City Labs Adopts Medicinal Genomics’ qPCR Technology for Cannabis Testing

CCT IMPACT Agent
Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety and transparency of cannabis, today announced that Rose City Labs, a multistate state operating organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Portland, OR, facility, the first in that state. Rose City......
Market Watch

SD PharmLabs, First Hemp Lab in Texas, Selects Medicinal Genomics for Microbial Testing

CCT IMPACT Agent
Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety and transparency of cannabis, today announced that SD PharmLabs, a multistate testing lab organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Texas hemp lab, the first in that state. Beyond testing, PharmLabs also......
CCT Impact

Medicinal Genomics Announces New PathoSEEK® Aspergillus Multiplex Assay to Streamline Cannabis Testing

CCT IMPACT Agent
Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety, and transparency of cannabis, today announced its new PathoSEEK® 5-Color Aspergillus Multiplex Assay that independently identifies four species of pathogenic Aspergillus— A. flavus, A. fumigatus, A. niger, and A. terreus — on cannabis samples using just one qPCR......
Market Watch

Medicinal Genomics, Arbor Biosciences Partner on Marker Discovery and Genotyping in Cannabis

CCT IMPACT Agent
Medicinal Genomics Corp. (MGC), a pioneer in genomics that improves the yield, safety, and transparency of cannabis, today announced a partnership with Arbor Biosciences, a division of Chiral Technologies, Inc. and worldwide leader in next generation sequencing (NGS) target enrichment, to introduce a new genotyping panel for cannabis. Together the......